RARA CRAFT DATABASE for FDA Medical Devices
510(k)K230416

FDA DEVICE FACTS

Triathlon® Hinge Knee System; Triathlon® Revision Insert X3®

Stryker

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 19, 2023PRODUCT CODEKRO

Indications for use

Triathlon® Hinge Knee System: Rotating Hinge Knee System is intended to be implanted with bone cement for the following condition(s): x There is destruction of the joint surfaces, with or without significant bone deformity. x The cruciate and/or collateral ligaments do not stabilize the knee joint. x The ligaments are inadequate and/or the musculature is weak. And/or x Revision is required of a failed prosthesis where there has been gross instability, with or without bone loss or inadequate soft tissue. x And/or where segmental resection and replacement of the distal femur is required. Triathlon® Revision Insert X3®: General Total Knee Arthroplasty (TKR) Indications: x Painful, disabling joint disease of the knee resulting from: noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis. x Post-traumatic loss of knee joint configuration and function. x Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability. x Revision of previous unsuccessful knee replacement or other procedure. x Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture-management techniques. Additional Indications for Total Stabilizer (TS) Components: x Ligamentous instability requiring implant bearing surface geometries with increased constraint. x Absent or non-functioning posterior cruciate ligament. x Severe anteroposterior instability of the knee joint. x Severe instability of the knee secondary to compromised collateral ligament integrity or function.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026